BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) announced today that total revenues were $492 million during the third quarter ended September 30, 2006, compared to $518 million in the third quarter of 2005. Including special items, net earnings equaled $90 million and diluted earnings per share equaled $0.37 during the third quarter ended September 30, 2006, compared to net income of $122 million and diluted earnings per share of $0.50 in the same period of the prior year. Excluding special items, net earnings equaled $106 million and diluted earnings per share equaled $0.44 during the third quarter ended September 30, 2006, compared to net earnings of $125 million and diluted earnings per share of $0.52 in the third quarter of 2005.
